Ann: FY24 Results Presentation, page-5

First 5 Last

Share
Profile

Follow
VascoDaG

835 Posts.

185

16/08/24

22:05

Post #: 75247062
Share

Originally posted by Sojourner: ↑

I'm really looking forward to this presentation. Despite the challenges of having to compound results on bigger and bigger numbers, the company has been increasing its rate of growth.

I continue to be amazed at how well the company is doing outside of the U.S. Sales outside of the U.S have traditionally been very challenging for new companies like Polynovo without an existing footprint, trying to navigate different markets outside of the U.S. So much so, that it is not unusual to see the growth rates for a new company like PNV to have growth rates in the rest of the world significantly lower than the growth rates in the U.S. This has not been the case for PNV, and I think a significant factor behind this success has been driven by surgeons themselves who have been publishing their papers on their use of BTM.

Despite PNV being an ASX200 company, this has not been widely held be institutions. I am only aware of two smaller fund managers holding this stock. I think this is set to change in the very near future (<12 months) for a number of reasons:

1. The stock has already passed its breakeven point and is likely to continue to grow profitability despite it not being a priority at all.
2. There is clear strategy being developed to expand the range of products the company has to address other market needs - each with its own massive underserved markets. It would also show the market more clearly that it is not a one product company
3. Consolidation of the company's product as 'the standard of care'. Unfortunately, there has been a long standing view from analysts that the company is still the little unknown upstart against the 400 pound gorilla, and that you needed to discount the stock heavily, given the inertia of its customers to move. I think the company has beyond proving this view incorrect, and when the broader market comes to that realisation, it would support a very quick jump in the stock price.
4. Consistent growth. In the few years around and after covid, the company's growth trajectory was inconsistent. This has been changing as the company has been delivering very good growth over a number of reporting periods - is it enough to change the mind of the market? Maybe it is, maybe the market will want another half, who knows for sure? What I do know is that the results for the past 18 months have been excellent and compelling.

At the end of the day, what matters is the company's ability to continue to grow and sustain that growth. The latest unaudited results shows that it is continue very well along that path, and there are a number of other catalysts I have not mentioned such as the BARDA trials, expansion into India etc, but those are additional factors that can further add fuel to the fire.

It would not be surprised if Christmas comes and we're at over $4.

Expand

I always find myself nodding to your well thought out and articulated analyses vs thesis at various points of times. I couldn’t agree more and these are some of the reasons I have held and keep buying.

PNV Price at posting: $2.61 Sentiment: Hold Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

DYL

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

PH2

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASM

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

BBT

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.24		Change 0.023(1.85%)		Mkt cap ! $856.6M

Open	High	Low	Value	Volume
$1.22	$1.25	$1.21	$794.1K	648.0K

Buyers (Bids)

No.	Vol.	Price($)
21	10378	$1.24

Sellers (Offers)

Price($)	Vol.	No.
$1.24	20124	17

View Market Depth

No.	Vol.	Price($)
14	5817	1.235
24	29520	1.230
15	27126	1.225
11	38145	1.220
10	73742	1.215

Price($)	Vol.	No.
1.240	16215	14
1.245	44357	17
1.250	91470	17
1.255	21388	8
1.260	20412	4

Last trade - 13.01pm 17/06/2025 (20 minute delay)

PNV (ASX) Chart

Ann: FY24 Results Presentation, page-5

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FY24 Results Presentation, page-5

Top Stories

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News